Couldn't agree more. This is a terrible deal for shareholders.Let the directors buy their shares back the hard way or if they can't afford to, then sell them and move on.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025